10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,415 | -13.2% | 41,004 | +17.5% | 0.08% | -11.7% |
| Q2 2023 | $1,949,095 | +46.2% | 34,905 | +46.1% | 0.09% | +30.6% |
| Q1 2023 | $1,333,102 | +258.1% | 23,895 | +133.9% | 0.07% | +213.0% |
| Q4 2022 | $372,271 | -26.0% | 10,216 | -42.2% | 0.02% | -30.3% |
| Q3 2022 | $503,000 | -35.1% | 17,666 | +3.1% | 0.03% | -21.4% |
| Q2 2022 | $775,000 | -32.8% | 17,136 | +13.0% | 0.04% | -16.0% |
| Q1 2022 | $1,153,000 | -75.3% | 15,160 | -51.6% | 0.05% | -77.3% |
| Q4 2021 | $4,668,000 | +43.9% | 31,337 | +40.6% | 0.22% | +20.2% |
| Q3 2021 | $3,244,000 | +4.6% | 22,284 | +24.0% | 0.18% | -14.1% |
| Q2 2021 | $3,100,000 | – | 17,967 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |